Skip to main content
Erschienen in: Breast Cancer Research 1/2000

01.03.2000 | Meeting abstract

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

verfasst von: J Alsner, M Yilmaz, P Guldberg, LL Hansen, J Overgaard

Erschienen in: Breast Cancer Research | Sonderheft 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

TP53 mutation is a strong independent marker for survival in breast cancer with some heterogeneity in the clinical phenotype of various types of mutations. Based on 315 patients with breast carcinoma, we suggest a new model for the differentiation of TP53 mutations. Although TP53 mutation in general was associated with aggressive tumour/patient characteristics, missense mutations outside any conserved or structural domain did not affect the clinical outcome (risk of disseminated disease and death). In contrast, patients with missense mutations affecting amino acids directly involved in DNA-or zinc-binding displayed a very aggressive clinical phenotype. Null mutations (including missense mutations disrupting the tetramerization domain) and the remaining missense mutations displayed an intermediate aggressive clinical phenotype. When patients were divided into 3 groups, (i) wild-type together with the missense mutations outside structural/conserved domains, (ii) null mutations and the missense with intermediate clinical phenotype, and (iii) the very aggressive missense mutations, disease-specific survival rates were 89%, 58%, and 35% (5-year actuarial values, P < 0.0001), respectively. In a Cox proportional hazards analysis, separation of TP53 mutations according to these criteria eliminated the prognostic importance of all investigated classical factors except nodal status. …
Metadaten
Titel
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
verfasst von
J Alsner
M Yilmaz
P Guldberg
LL Hansen
J Overgaard
Publikationsdatum
01.03.2000
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 1/2000
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr109

Weitere Artikel der Sonderheft 1/2000

Breast Cancer Research 1/2000 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.